ReviewJournal of plant research2021
×Sorbaronia mitschurinii: from an artificially created species to an invasion in Europe: repeating the fate of invasive Amelanchier ×spicata, a review.
Review in Journal of plant research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 12 citations in OpenAlex.
- Review
- Comparative Analysis of Phenolic Profiles and Antioxidant Activity in the Leaves of InvasivePlants (Basel, Switzerland) · 2025Article
- New Year's greetings 2022 from the Journal of Plant Research.Journal of plant research · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
Abstract
By intervening in natural events, relocating species to other areas, purposefully hybridizing them, as well as reducing the habitats required for them, humans have created conditions for new hybrid species to emerge. As long as hybrids exist in our gardens and fields, we have no reason to worry. However, problems arise with the expansion of these hybrid species into natural habitats, where such hybrid species cannot always be recognized and remain unnoticed, and in most cases they are often mistaken for natural parent species. Two hybrid species, Amelanchier ×spicata and ×Sorbaronia mitschurinii have historically developed in Europe with different scenarios of origin. It has been suggested in the past that both species are of hybrid origin, and recent molecular studies have confirmed the previous assumptions. There is no doubt that A. ×spicata originated in a natural way of hybridization, when the two parental species came into contact in Europe, but ×S. mitschurinii is a purposefully created species, crossing ×Sorbaronia fallax with Aronia melanocarpa. Produced as a result of different scenarios, these two hybrid species have become invasive in Europe, and ×S. mitschurinii has started to follow in the footsteps of the highly invasive A. ×spicata, spreading in the wild, where it predominantly expands in pine forests and in wetland forests along water bodies and bogs. Moreover, ×S. mitschurinii occupies the same habitats in Europe as one of its parent plants, A. melanocarpa in North America, and this species is a threat to wetland forest habitats. Given that ×S. mitschurinii has long been regarded as one of Aronia species, the exact distribution of the species in Europe is unknown, but the following countries are currently reporting the presence of the species in Europe: Belarus, Belgium, Czech Republic, Estonia, Finland, Latvia, Lithuania, Netherlands, Norway, Poland, Russian Federation, Sweden, Ukraine and United Kingdom. In the light of current knowledge, further studies on ×S. mitschurinii invasion in Europe are needed, as well as the need to correct the information in international databases, such as CABI, NOBANIS, to separate ×S. mitschurinii data from what applies to Aronia taxa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.